PT Millennium Pharmacon International Tbk (IDX:SDPC)
192.00
+2.00 (1.05%)
Nov 20, 2026, 3:46 PM WIB
IDX:SDPC Revenue
PT Millennium Pharmacon International Tbk had revenue of 1.15T IDR in the quarter ending September 30, 2026, with 8.50% growth. This brings the company's total for the last twelve months to 4.39T, up 9.85% year-over-year. In the year 2025, PT Millennium Pharmacon International Tbk had annual revenue of 4.11T with 4.93% growth. That makes PT Millennium Pharmacon International Tbk the 16,185th largest company in the world by revenue and 216th in Indonesia.
Revenue (ttm)
4.39T
Revenue Growth
+9.85%
P/S Ratio
0.06
Revenue / Employee
3.66B
Employees
1,199
Market Cap
244.61B
Revenue by Segment
- Prescription Medicines 2.89T 70.3%
- Medical Equipment 1.08T 26.2%
- Non-Prescription Medicines 143.45B 3.5%
- Others 382.50M 0.0%
Fiscal year ended Dec 31, 2025 See the full IDX:SDPC breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.11T | 192.95B | 4.93% |
| Dec 31, 2024 | 3.92T | 553.35B | 16.45% |
| Dec 31, 2023 | 3.36T | 162.68B | 5.08% |
| Dec 31, 2022 | 3.20T | 211.98B | 7.09% |
| Dec 31, 2021 | 2.99T | 345.22B | 13.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Enseval Putera Megatrading Tbk. | 35.63T |
| PT Medela Potentia Tbk | 16.28T |
| PT Soho Global Health Tbk | 11.13T |
| PT Kimia Farma Tbk | 9.29T |
| PT Itama Ranoraya Tbk | 1.04T |
| PT Diastika Biotekindo Tbk | 224.95B |
| PT Esa Medika Mandiri Tbk | 223.91B |